Written by zgiaonews• February 20, 2024• 10:09 am• AI, Discussions

– Bioptimus, an AI Startup Founded by Former Googlers, Secures $35M Funding with Impressive 12-Slide Pitch Deck

HomeAI, Discussions– Bioptimus, an AI Startup Founded by Former Googlers, Secures $35M Funding with Impressive 12-Slide Pitch Deck

Bioptimus is the latest AI startup to emerge from France, with the company looking to create models…

AI Startup Founded by Former Google Employees Secures $35 Million in Funding: A Look at Bioptimus’ 12-Slide Pitch Deck

By Callum Burroughs

French AI startup Bioptimus has successfully raised $35 million in seed funding, spearheaded by its CEO, Jean-Philippe Vert, a former research scientist at Google. The company, established in 2023, focuses on leveraging AI in the realm of life sciences, aiming to revolutionize innovation in fields such as biology and life sciences by harnessing the power of data analytics.

Vert highlighted the pivotal role of AI in accelerating advancements in biomedical research, emphasizing the shift towards AI as the primary driver of progress in data-rich domains like biology. Unlike traditional approaches, Bioptimus intends to develop foundational models using scientific data rather than generic internet text data, tapping into a wealth of publicly available and open-source information as well as collaborating with research institutions and consortiums.

The startup’s areas of interest encompass a wide array of applications, ranging from the creation of novel bio proteins for medical purposes to enhancing data analysis techniques for cancer research. The $35 million seed funding round, led by Sofinnova Partners and supported by investors like Bpifrance Large Venture, Frst.vc, and Cathay Innovation, among others, signifies a strong endorsement of Bioptimus’ vision and capabilities.

Noteworthy supporters of the venture include Owkin, Vert’s former workplace, and prominent tech entrepreneur Xavier Niel. The fundraising process, initiated in the summer of 2023, culminated successfully, reflecting the industry’s receptiveness to cutting-edge AI technologies and Bioptimus’ unique blend of expertise, data access, and team quality.

With a focus on acquiring computational resources, expanding data accessibility, and bolstering its workforce, Bioptimus plans to scale up its operations significantly, aiming to reach a staff count of approximately 20 by the year’s end. This strategic allocation of funds underscores the company’s commitment to driving innovation and pushing the boundaries of AI applications in the realm of life sciences.

Explore Bioptimus’ detailed 12-slide seed pitch deck below: